Showing results (241-250 of 399) with videos related to

Sort By:
Pageof 40
Cancer Research|November 23, 2021
Plasticity in the Absence of NOTCH Uncovers a RUNX2-Dependent Pathway in Small Cell Lung CancerDeli Hong, Erik H Knelson, Yixiang Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2025
Molecular characterization of NUT carcinoma: a report from the NUT carcinoma registryJustin J Kim, Sara A Walton, Navin R Mahadevan, et al.
Nature Medicine|December 7, 2021
Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trialDaniel J DeAngelo, Deepti H Radia, Tracy I George, et al.
Cancer|January 19, 2023
Psychological mobile app for patients with acute myeloid leukemia: A pilot randomized clinical trialAreej El-Jawahri, Marlise R Luskin, Joseph A Greer, et al.
Leukemia|July 5, 2022
Efficacy of avapritinib versus best available therapy in the treatment of advanced systemic mastocytosisAndreas Reiter, Jason Gotlib, Iván Álvarez-Twose, et al.
Blood|January 1, 2015
Acute myeloid leukemia ontogeny is defined by distinct somatic mutationsR Coleman Lindsley, Brenton G Mar, Emanuele Mazzola, et al.
The Lancet. Oncology|February 29, 2024
Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody-drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 studyNaval G Daver, Pau Montesinos, Daniel J DeAngelo, et al.
Frontiers in Immunology|October 5, 2020
Tumor-Derived cGAMP Regulates Activation of the VasculatureMarco Campisi, Shriram K Sundararaman, Sarah E Shelton, et al.
Nature Medicine|February 14, 2017
The creatine kinase pathway is a metabolic vulnerability in EVI1-positive acute myeloid leukemiaNina Fenouille, Christopher F Bassil, Issam Ben-Sahra, et al.
Leukemia|July 20, 2024
Subunit-specific analysis of cohesin-mutant myeloid malignancies reveals distinct ontogeny and outcomesJohann-Christoph Jann, Christopher B Hergott, Marisa Winkler, et al.
Pageof 40